We are live on ! Find out more
NRIX icon

Nurix Therapeutics
NRIX

68 hedge funds and large institutions have $1.09B invested in Nurix Therapeutics in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 12

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

25% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 12

3% more funds holding

Funds holding: 66 → 68 (+2)

0.72% less ownership

Funds ownership: 86% → 85.28% (-0.72%)

2% less capital invested

Capital invested by funds: $1.11B → $1.09B (-$21.9M)

Holders
68
Holders Change
+2
Holders Change %
+3.03%
% of All Funds
1.2%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.11%
New
15
Increased
27
Reduced
12
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EAM
Eventide Asset Management
Massachusetts
+$18.3M
2
BlackRock
BlackRock
New York
+$16.6M
3
EC
EcoR1 Capital
California
+$11.7M
4
State Street
State Street
Massachusetts
+$10.6M
5
RG
Redmile Group
California
+$8.37M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$30.5M
2
Citadel Advisors
Citadel Advisors
Florida
-$7.82M
3
BC
Boxer Capital
California
-$4.29M
4
Ameriprise
Ameriprise
Minnesota
-$4.19M
5
WMSA
Weiss Multi-Strategy Advisers
New York
-$1.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$5.25M +$5.29M +159,549 New
Northern Trust
27
Northern Trust
Illinois
$4.53M +$148K +4,474 +3%
Ameriprise
28
Ameriprise
Minnesota
$4.24M -$4.19M -126,448 -50%
Millennium Management
29
Millennium Management
New York
$3.72M +$3.75M +113,204 New
N
30
Nuveen
North Carolina
$3.25M +$1.06M +31,991 +48%
Charles Schwab
31
Charles Schwab
California
$2.53M +$154K +4,662 +6%
APM
32
Avidity Partners Management
Texas
$1.64M – – –
Wells Fargo
33
Wells Fargo
California
$1.56M +$406K +12,261 +35%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$1.46M +$546K +16,482 +59%
TD Asset Management
35
TD Asset Management
Ontario, Canada
$1.25M – – –
Swiss National Bank
36
Swiss National Bank
Switzerland
$825K +$832K +25,100 New
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$811K -$16.6K -500 -2%
CS
38
Credit Suisse
Switzerland
$584K +$589K +17,782 New
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$579K +$27K +815 +5%
State of Wisconsin Investment Board
40
State of Wisconsin Investment Board
Wisconsin
$516K +$520K +15,700 New
DekaBank Deutsche Girozentrale
41
DekaBank Deutsche Girozentrale
Germany
$465K +$411K +12,400 New
Deutsche Bank
42
Deutsche Bank
Germany
$429K +$235K +7,105 +120%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$382K +$69.9K +2,110 +22%
Victory Capital Management
44
Victory Capital Management
Texas
$356K -$15.1K -457 -4%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$343K +$136K +4,100 +65%
Citadel Advisors
46
Citadel Advisors
Florida
$302K -$7.82M -236,016 -96%
Morgan Stanley
47
Morgan Stanley
New York
$289K +$234K +7,069 +409%
ProShare Advisors
48
ProShare Advisors
Maryland
$282K +$284K +8,580 New
SFI
49
Susquehanna Fundamental Investments
Pennsylvania
$273K -$23.2K -700 -8%
Bank of America
50
Bank of America
North Carolina
$239K -$41.8K -1,262 -15%
1
2
3 4

NRIX Hedge Fund Activity: Q4 2020 in Review

68 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Nurix Therapeutics (NRIX) for Q4 2020, worth a combined $1.09B — down 2% from $1.11B a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new NRIX positions and 12 closed out — a net gain of 3 holders — while 27 added to existing stakes and 12 trimmed.

The largest buyer was Eventide Asset Management, adding an estimated $18.3M. The largest seller was Wellington Management Group, cutting an estimated $30.5M.

  • 68 institutional investors held Nurix Therapeutics (NRIX) as of Q4 2020, up from 66 in Q3 2020.
  • Funds reported $1.09B of Nurix Therapeutics stock for Q4 2020, down 2% quarter-over-quarter.
  • 15 funds opened new Nurix Therapeutics positions in Q4 2020 and 12 closed out, a net change of +3 holders.
  • The largest Nurix Therapeutics buyer in Q4 2020 was Eventide Asset Management, an estimated $18.3M added.
  • The largest Nurix Therapeutics seller in Q4 2020 was Wellington Management Group, an estimated $30.5M sold.

Based on aggregated 13F filings for Q4 2020.